Cargando…
Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Although standard-of-care chemotherapeutics are sufficient for most ALL cases, there are subsets of patients with poor response who relapse in disease. The biology underlying differences between subtypes and their response to th...
Autores principales: | Leo, Isabelle Rose, Aswad, Luay, Stahl, Matthias, Kunold, Elena, Post, Frederik, Erkers, Tom, Struyf, Nona, Mermelekas, Georgios, Joshi, Rubin Narayan, Gracia-Villacampa, Eva, Östling, Päivi, Kallioniemi, Olli P., Tamm, Katja Pokrovskaja, Siavelis, Ioannis, Lehtiö, Janne, Vesterlund, Mattias, Jafari, Rozbeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967900/ https://www.ncbi.nlm.nih.gov/pubmed/35354797 http://dx.doi.org/10.1038/s41467-022-29224-5 |
Ejemplares similares
-
Prediction model for drug response of acute myeloid leukemia patients
por: Trac, Quang Thinh, et al.
Publicado: (2023) -
FORALL: an interactive shiny/R web portal to navigate multi-omics high-throughput data of pediatric acute lymphoblastic leukemia
por: Aswad, Luay, et al.
Publicado: (2023) -
Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia
por: Yang, Minjun, et al.
Publicado: (2019) -
Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment
por: Dyczynski, Matheus, et al.
Publicado: (2018) -
TcellSubC: An Atlas of the Subcellular Proteome of Human T Cells
por: Joshi, Rubin Narayan, et al.
Publicado: (2019)